Literature DB >> 1354613

Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.

S Fuerstenberg1, I Leitner, C Schroeder, H Schwarz, B Vennström, H Beug.   

Abstract

The v-erbA oncogene confers two prominent properties on transformed erythroblasts: a block of spontaneous differentiation and tolerance to wide variations in the pH or ionic strength of culture medium. V-erbA acts as a constitutive repressor of erythrocyte-specific gene transcription, arresting the expression of at least three different erythroid genes: the erythrocyte anion transporter (band 3), carbonic anhydrase II (CAII) and delta-aminolevulinate synthase (ALA-S). To test whether or not the v-erbA induced repression of these genes is causally related to the v-erbA induced leukaemic phenotype, we have reintroduced the genes for band 3 or CAII into transformed erythroblasts via retrovirus vectors. We show here that such erythroblasts, expressing v-erbA, require the same narrow range of medium pH and ion concentration for growth as do transformed erythroblasts lacking v-erbA, i.e. the v-erbA induced tolerance to pH variation was abrogated. The v-erbA induced differentiation block, however, remained unaffected by the re-expression of band 3 and was only slightly affected by the re-expression of CAII. Our experiments show that the two v-erbA-related 'erythroblast transformation parameters' are separable: suppression of band 3 and CAII accounts for one parameter (pH/ion tolerance), while the second parameter (differentiation block) must involve v-erbA regulation of a different set of target genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354613      PMCID: PMC556870          DOI: 10.1002/j.1460-2075.1992.tb05414.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  59 in total

1.  Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.

Authors:  B G Bonde; M Sharif; M L Privalsky
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.

Authors:  H de Verneuil; D Metzger
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

3.  Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.

Authors:  D Forrest; A Muñoz; C Raynoschek; B Vennström; H Beug
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

4.  Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product.

Authors:  J Sap; A Muñoz; J Schmitt; H Stunnenberg; B Vennström
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

5.  Temperature-sensitive v-sea transformed erythroblasts: a model system to study gene expression during erythroid differentiation.

Authors:  J Knight; M Zenke; C Disela; E Kowenz; P Vogt; J D Engel; M J Hayman; H Beug
Journal:  Genes Dev       Date:  1988-02       Impact factor: 11.361

6.  Temperature-sensitive mutant of avian erythroblastosis virus suggests a block of differentiation as mechanism of leukaemogenesis.

Authors:  T Graf; N Ade; H Beug
Journal:  Nature       Date:  1978-10-12       Impact factor: 49.962

7.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

8.  EGF-R as a hemopoietic growth factor receptor: the c-erbB product is present in chicken erythrocytic progenitors and controls their self-renewal.

Authors:  B Pain; C M Woods; J Saez; T Flickinger; M Raines; S Peyrol; C Moscovici; M G Moscovici; H J Kung; P Jurdic
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

9.  The carbonic anhydrase II gene, a gene regulated by thyroid hormone and erythropoietin, is repressed by the v-erbA oncogene in erythrocytic cells.

Authors:  B Pain; F Melet; P Jurdic; J Samarut
Journal:  New Biol       Date:  1990-03

10.  Phosphorylation of the v-erbA protein is required for its function as an oncogene.

Authors:  C Glineur; M Zenke; H Beug; J Ghysdael
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

View more
  11 in total

1.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Authors:  F Moreau-Gachelin; F Wendling; T Molina; N Denis; M Titeux; G Grimber; P Briand; W Vainchenker; A Tavitian
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

2.  Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.

Authors:  K Damm; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

3.  Transcriptional repression by the human bZIP factor E4BP4: definition of a minimal repression domain.

Authors:  I G Cowell; H C Hurst
Journal:  Nucleic Acids Res       Date:  1994-01-11       Impact factor: 16.971

4.  D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain.

Authors:  B Ganter; S l Fu; J S Lipsick
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

5.  The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.

Authors:  A Bauer; W Mikulits; G Lagger; G Stengl; G Brosch; H Beug
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

6.  Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.

Authors:  P Ciana; G G Braliou; F G Demay; M von Lindern; D Barettino; H Beug; H G Stunnenberg
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

7.  Mammalian granulocyte-macrophage colony-stimulating factor receptor expressed in primary avian hematopoietic progenitors: lineage-specific regulation of proliferation and differentiation.

Authors:  O Wessely; E M Deiner; K C Lim; G Mellitzer; P Steinlein; H Beug
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

8.  Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA.

Authors:  C Barlow; B Meister; M Lardelli; U Lendahl; B Vennström
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

9.  Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR.

Authors:  D Barettino; T H Bugge; P Bartunek; M D Vivanco Ruiz; V Sonntag-Buck; H Beug; M Zenke; H G Stunnenberg
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

10.  The estrogen receptor cooperates with the TGF alpha receptor (c-erbB) in regulation of chicken erythroid progenitor self-renewal.

Authors:  C Schroeder; L Gibson; C Nordström; H Beug
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.